CSW Industrials Reports Record Results

By Bobby Samwell • Thursday, May 22 15:20 • Permanent Link

CSW Industrials, Inc. has reported record results for the fiscal 2025 fourth quarter and full year. In the fourth quarter, total revenue increased by 9.3% to a record of $230.5 million, driven by 6.3% inorganic growth from recent acquisitions and 3.0% organic growth. Net income attributable to CSWI increased by 18.7% to a fourth quarter record of $35.1 million.

For the full fiscal year, total revenue increased by 10.8% to $878.3 million, with $47.5 million from recent acquisitions and 4.8% from organic growth. Net income attributable to CSWI increased by 25.7% to $136.7 million.

The company invested $84.7 million in acquisitions and $16.3 million in organic capital expenditures, while returning a total cash of $32.9 million to shareholders through share repurchases and dividends.

Following the fiscal year-end, CSW Industrials announced the transfer of the listing of common stock to the New York Stock Exchange and a change in ticker symbol to "CSW."

The effective tax rate for the fiscal fourth quarter was 24.6%, and for the full fiscal year, the rate was 23.7% on a GAAP basis and 25.5% as adjusted.

In terms of segment results, the contractor solutions segment revenue increased by 17.5% in the fourth quarter and by 15.1% for the full fiscal year, driven by both inorganic and organic growth. The specialized reliability solutions segment revenue decreased by 9.2% in the fourth quarter, while the engineered building solutions segment revenue decreased by 4.5%.

CSW Industrials reported a 13.9% increase in adjusted EBITDA to $227.9 million for the full fiscal year, with an improved EBITDA margin of 25.9%.

The market has reacted to these announcements by moving the company's shares -3.18% to a price of $304.45. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.